AB

Axel Behrens

Chief Scientific Officer and Co-founder

Analona Therapeutics

Therapeutic Areas

Analona Therapeutics Pipeline

DrugIndicationPhase
Undisclosed Metabolic DisruptorHigh medical need solid tumorsPreclinical